Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

FDA Getting Reg Slashing Directive In Trump Executive Order

Jun 24 2017

• By Derrick Gingery

FDA entrance sign 2016

Related Content

Complex Generics May Be Part Of White House Drug Pricing Response

Jun 22 2017

Trump Exec Order On Drug Costs: Seeking To Balance Access, Innovation

Jun 24 2017

US FDA Likely Not 'Significant', Could Be Mostly Spared From Trump's Regulation-Slashing Order

Feb 10 2017

US FDA 'Medical Innovation Development Plan' Outlined By Gottlieb

Jun 21 2017

Additional Topics

United States Pricing Debate Generic Drugs FDA Policy BioPharmaceutical

More from Pricing Debate

More from Market Access

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window